🇺🇸 FDA
Patent

US 11833210

ASH1L inhibitors and methods of treatment therewith

granted A61KA61K31/404A61K31/454

Quick answer

US patent 11833210 (ASH1L inhibitors and methods of treatment therewith) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/404, A61K31/454, A61K31/4545, A61K38/45